arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Cypherpunk Technologies Inc.

CYPH Health Care Biotechnology: Pharmaceutical Preparations
$2.82
▼ -15.3% Today
as of Oct 23, 16:48 ET
Last 30 days +9.30% Sep 14 → Oct 23
$2.07 $2.62 $3.17 $3.72 $4.27 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$2.97
High
$3.11
Low
$2.74
Volume
$10M
Avg Vol
$11M
Mkt Cap
$315M
P/E (TTM)
—
Beta
—
52w High
$4.19
52w Low
$0.39
Div Yield
—
Shares Out
$108M

Recent Press Releases & News last 60 days · 1 item

Oct 12 · 17:37 Stocktwits
Winklevoss Twins-Backed Cypherpunk Says Zcash Mining Is 'Nowhere Close' To Bitcoin, AI — Sees $10K Potential

CYPH earnings at a glance

The options market is pricing a move of about ±14.7% after the report, a range of roughly $2.41 to $3.23 from today's $2.82. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±11.0% on average; after the most recent report on May 14, 2026 it moved +15.4%. That means options currently expect more movement than CYPH has typically delivered. CYPH beat the consensus EPS estimate in 2 of its last 3 reported quarters. Implied volatility is currently 249%. The share price of $2.82 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.39
$4.19
64% of range
Avg surprise (last 3)
+10.5%
Avg reaction (last 2)
+11.0%
100% positive
Latest IV / EM
249%
EM ±14.7% · $3 · Oct 9

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.24$-2.39$-1.53$-0.67$0.18 Actual $-3.24Actual $-0.91Actual $-0.51Actual $-0.51Actual $-0.52Actual $-0.44Actual $-0.37Est $-0.38Actual $-0.40Est $-0.29Actual $-0.08Est $-0.24Actual $0.18 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-77M$-48M$-18M$12M$41M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.18 — — — — financials
Thu May 14, 2026Mar/2026 — — — +100.0% +15.4% earnings
Wed Nov 12, 2025Sep/2025 $-0.08 $-0.24 +66.7% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.40 $-0.29 -37.9% — — earnings
Tue May 13, 2025Mar/2025 $-0.37 $-0.38 +2.6% — +6.7% earnings
Mon Sep 30, 2024Sep 2024 $-0.44 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.52 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.51 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.51 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.91 — — — — financials
Fri Mar 31, 2023Mar 2023 $-3.24 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income$-5M$-5M—$-3M$-17M$-16M—$-18M
Net income$39M$-77M—$-3M$-17M$-15M—$-18M
EPS (diluted)$0.18$-0.46—$-0.08$-0.40$-0.37—$-0.44

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$8M$7M$14M$10M$18M$33M$47M$63M
Inventory————————
Total current assets$138M$82M$162M$10M$19M$34M$48M$64M
Total assets$143M$87M$163M$11M$20M$35M$49M$65M
Long-term debt————————
Total liabilities$4M$3M$10M$9M——$14M$16M
Total equity$139M$84M$154M$3M$6M$21M$35M$49M

Implied volatility — last 90 days

142%538%935%1331%1728% Jun 07 — IV 417% · EM ±57.8%Jun 08 — IV 519% · EM ±68.5%Jun 09 — IV 413% · EM ±51.8%Jun 10 — IV 456% · EM ±53.8%Jun 15 — IV 780% · EM ±56.4%Jun 16 — IV 1085% · EM ±64.1%Jun 17 — IV 1728% · EM ±72.2%Jun 19 — IV 337% · EM ±74.4%Jun 22 — IV 423% · EM ±88.3%Jun 26 — IV 457% · EM ±87.4%Jun 29 — IV 489% · EM ±86.6%Jul 02 — IV 232% · EM ±37.5%Jul 03 — IV 240% · EM ±37.5%Jul 06 — IV 269% · EM ±37.3%Jul 07 — IV 379% · EM ±50.0%Jul 09 — IV 613% · EM ±72.5%Jul 14 — IV 945% · EM ±68.3%Jul 20 — IV 361% · EM ±85.4%Jul 21 — IV 262% · EM ±60.9%Jul 22 — IV 423% · EM ±96.7%Jul 23 — IV 471% · EM ±105.9%Jul 24 — IV 473% · EM ±104.6%Jul 27 — IV 267% · EM ±55.8%Jul 28 — IV 279% · EM ±57.0%Jul 29 — IV 374% · EM ±75.0%Jul 30 — IV 490% · EM ±95.9%Jul 31 — IV 442% · EM ±84.7%Aug 03 — IV 576% · EM ±102.1%Aug 04 — IV 715% · EM ±123.2%Aug 05 — IV 408% · EM ±68.2%Aug 06 — IV 459% · EM ±74.2%Aug 07 — IV 372% · EM ±58.1%Aug 10 — IV 372% · EM ±51.5%Aug 11 — IV 501% · EM ±66.2%Aug 12 — IV 425% · EM ±53.2%Aug 13 — IV 577% · EM ±68.2%Aug 14 — IV 492% · EM ±54.3%Aug 17 — IV 764% · EM ±63.8%Aug 18 — IV 627% · EM ±45.3%Aug 19 — IV 316% · EM ±18.6%Aug 20 — IV 503% · EM ±21.0%Aug 24 — IV 166% · EM ±34.6%Aug 25 — IV 156% · EM ±32.0%Aug 26 — IV 161% · EM ±32.2%Aug 27 — IV 156% · EM ±30.6%Aug 28 — IV 160% · EM ±30.6%Aug 31 — IV 179% · EM ±31.7%Sep 01 — IV 173% · EM ±29.8%Sep 02 — IV 160% · EM ±26.8%Sep 03 — IV 166% · EM ±26.9%Sep 04 — IV 165% · EM ±25.8%Sep 07 — IV 186% · EM ±25.8%Sep 08 — IV 164% · EM ±21.7%Sep 09 — IV 189% · EM ±23.7%Sep 10 — IV 201% · EM ±23.7%Sep 11 — IV 196% · EM ±21.6%Sep 14 — IV 210% · EM ±17.5%Sep 15 — IV 218% · EM ±15.8%Sep 16 — IV 207% · EM ±12.2%Sep 17 — IV 839% · EM ±35.1%Sep 21 — IV 169% · EM ±35.2%Sep 22 — IV 194% · EM ±39.8%Sep 23 — IV 169% · EM ±33.8%Sep 24 — IV 172% · EM ±43.0%Sep 25 — IV 142% · EM ±35.2%Sep 28 — IV 185% · EM ±43.6%Sep 29 — IV 158% · EM ±36.8%Sep 30 — IV 188% · EM ±11.1%Oct 01 — IV 266% · EM ±11.1%Oct 06 — IV 341% · EM ±24.7%Oct 07 — IV 249% · EM ±14.7%

Sector peers

PRLD
Prelude Therapeutics Incorporated
$302M $3.63-0.6%
BNTC
Benitec Biopharma Inc.
$334M $8.65+1.8%
ABEO
Abeona Therapeutics Inc.
$286M $4.40-2.4%
INDP
Indaptus Therapeutics, Inc.
$282M $3.160.0%
EBS
Emergent BioSolutions Inc.
$363M $6.23+0.5%
BCYC
Bicycle Therapeutics plc
$261M $3.55-0.6%

CYPH earnings FAQ

What is CYPH's expected move for earnings?

Options currently price a move of about ±14.7%, or $0.41 per share either way from $2.82.

How does CYPH stock usually react to earnings?

Across the last 2 reports the average next-day move was ±11.0%, up 2 times and down 0 times.

What is CYPH's implied volatility?

CYPH's at-the-money implied volatility is about 249% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in